You are here

  • Home
  • Archive
  • Volume 71, Issue Suppl 3
  • AB0565 Discontinuance of methotrexate and prednisolone in treatment with tocilizumab but not with infliximab or etanercept in rheumatoid arthritis patients with high disease activity. (Monotherapy by tocilizumab)

Alerts

Article menu
Download PDFPDF
Scientific Abstracts
Abstracts accepted for publication
Rheumatoid arthritis – other biologic treatment
AB0565 Discontinuance of methotrexate and prednisolone in treatment with tocilizumab but not with infliximab or etanercept in rheumatoid arthritis patients with high disease activity. (Monotherapy by tocilizumab)
You need to be signed in to access email alerts. If you have an account log in with your user name and password. If you don't have an account you can just enter your email address in the email box below.
Sign In to Email Alerts with your Email Address